In a new step forward on the quest for better painkillers, scientists have developed a synthetic cannabinoid that keeps the ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

Cannabinoid-induced poisonings are leading to more hospital admissions as drug traffickers target puff bars, gummies, and ...

When it comes to cannabis compounds, THC and CBD get top billing, but they are just two of over 100 chemicals known as ...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome. Researchers at the George Washington ...

Regularly taking large amounts of cannabis might cause cannabinoid hyperemesis syndrome (CHS). CHS leads to severe nausea and vomiting that doesn't respond to typical anti-nausea drugs.

In a collaboration between Washington University School of Medicine in St. Louis and Stanford University, researchers have developed a cannabinoid compound that provides pain relief without the ...

Discover how cannabinoid receptor type 1 (CB1) influences resilience to stress and its potential in treating anxiety and ...

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...